These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6489614)

  • 21. Dissociation of delayed-type hypersensitivity from acquired murine resistance to Brucella suis.
    Escande A; Cannat A; Serre A
    Ann Immunol (Paris); 1980; 131D(2):199-204. PubMed ID: 7469385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism between two immunogens extracted from Brucella (cell wall peptidoglycan and lipopolysaccharide fractions) and inactivity of the brucellin allergen in immunization of the mouse.
    Bosseray N; Plommet M
    Ann Microbiol (Paris); 1980; 131A(2):157-69. PubMed ID: 7387055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of Brucella canis surface antigens associated with colonial mucoidiness.
    Zoha SJ; Carmichael LE
    Cornell Vet; 1981 Oct; 71(4):428-38. PubMed ID: 6172238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of L-forms of Streptococcus pyogenes and their antitumor effects.
    Yamamoto A; Homma JY; Usami H; Sugawara Y
    Jpn J Exp Med; 1980 Oct; 50(5):383-8. PubMed ID: 7009927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of non-type-specific protein antigens of the cell wall in Streptococcus group A in developing delayed hypersensitivity].
    Bazanova EA; Bukhova VP; Liampert IM
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):67-71. PubMed ID: 2446447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure to 2.45 A resolution of a monoclonal Fab specific for the Brucella A cell wall polysaccharide antigen.
    Rose DR; Przybylska M; To RJ; Kayden CS; Oomen RP; Vorberg E; Young NM; Bundle DR
    Protein Sci; 1993 Jul; 2(7):1106-13. PubMed ID: 8358294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed hypersensitivity to syngeneic or xenogeneic testicular cells in guinea-pigs.
    Yoshida S; Nomoto K; Himeno K; Sanui H
    Immunology; 1981 Mar; 42(3):445-9. PubMed ID: 7203531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.
    Howard JG; Nicklin S; Hale C; Liew FY
    J Immunol; 1982 Nov; 129(5):2206-12. PubMed ID: 7119442
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella.
    De Bolle X; Laurent T; Tibor A; Godfroid F; Weynants V; Letesson JJ; Mertens P
    J Mol Biol; 1999 Nov; 294(1):181-91. PubMed ID: 10556037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological properties and dog response to a variant (M-) strain of Brucella canis.
    Carmichael LE; Zoha SJ; Flores-Castro R
    Dev Biol Stand; 1984; 56():649-56. PubMed ID: 6489639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of monoclonal antibodies against Brucella melitensis.
    Greiser-Wilke I; Moennig V; Thon D; Rauter K
    Zentralbl Veterinarmed B; 1985 Sep; 32(8):616-27. PubMed ID: 3907209
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed hypersensitivity in mast-cell-deficient mice.
    Thomas WR; Schrader JW
    J Immunol; 1983 Jun; 130(6):2565-7. PubMed ID: 6602168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The comparative characteristics of the immunogenic and immunomodulating activity of different antigenic preparations of the causative agent of Q fever Coxiella burnetii].
    Tokarevich NK; Pogodina ON; Freĭdlin IS; Kuzina VA; Kramskaia TA; Artemenko NK
    Tsitologiia; 1994; 36(11):1102-12. PubMed ID: 7535962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-2-dependent cell-mediated immunity in vivo: delayed-type hypersensitivity and contact sensitization induced by fluorescein isothiocyanate-conjugated cells.
    Domoto DT; Askenase PW
    J Immunol; 1980 Nov; 125(5):2161-6. PubMed ID: 7430623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic structure of Streptococcus pyogenes L forms.
    Havlícek J; Havlícková H
    Pathol Microbiol (Basel); 1967; 30(4):469-80. PubMed ID: 4963377
    [No Abstract]   [Full Text] [Related]  

  • 37. Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system.
    Furrie E; Turner MW; Strobel S
    Immunology; 1994 Dec; 83(4):562-7. PubMed ID: 7875736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serological cross reactivity of Yersinia enterocolitis serotype 9 with anti-Brucella sera in a district with brucellosis incidences].
    Huang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Feb; 3(1):30-2. PubMed ID: 7185430
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed-type hypersensitivity to liver F antigen in the mouse.
    Cooper PC; Coffey MF; Anders RF; MacKay IR
    J Immunol; 1980 Feb; 124(2):790-4. PubMed ID: 7356713
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations on L-forms of Yersinia enterocolitica.
    Pease P
    J Med Microbiol; 1979 Aug; 12(3):337-46. PubMed ID: 112256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.